ACADIA Pharmaceuticals, Inc. (ACAD)
21.25
-0.51
(-2.34%)
USD |
NASDAQ |
Apr 16, 16:00
21.61
+0.36
(+1.69%)
After-Hours: 20:00
ACADIA Pharmaceuticals Market Cap : 3.623B for April 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 30.78B |
| Madrigal Pharmaceuticals, Inc. | 12.04B |
| Merck & Co., Inc. | 285.46B |
| Axsome Therapeutics, Inc. | 9.422B |
| Marker Therapeutics, Inc. | 26.84M |
Market Cap Related Metrics
| PE Ratio | 9.286 |
| PS Ratio | 3.363 |
| PEG Ratio | 0.136 |
| Price to Book Value | 2.952 |
| Price to Free Cash Flow | 571.30 |
| Price | 21.25 |
| Earnings Yield | 10.77% |
| PEGY Ratio | 0.136 |
| Operating PE Ratio | 34.38 |
| Normalized PE Ratio | 9.286 |